Comments
Shares of pharma major Lupin will remain in focus, as the company on Monday said it has launched its testosterone topical solution in the United States. The company has launched Testosterone Topical Solution, 30 mg per actuation, in the US after receiving approval from the United States Food and Drug Administration, Lupin said. The company’s product is the generic version of Eli Lilly and the company’s Axiron topical solution, 30 mg per actuation, it added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.